Introduction and scientific goal
The establishment of genetically encoded markers of various neuronal cell populations and the concomitant rapid development of novel imaging modalities in the last two decades revealed the unparalleled functional and morphological complexity of neuronal networks. This complexity arises from the heterogeneity of neuronal cell populations. In the last couple of years, a considerable number of genetically and functionally distinguishable types of interneurons have been described. Up to now, no method for the specific stimulation of those diverse network components had been available. Electrical stimulation of neurons leads to an unspecific excitation. Methods such as uncaging, which combine pharmacological and optical strategies, require the continuous application of substrates, rendering in vivo applications unfeasible. Already in 1979 Francis Crick called for novel methods to stimulate neurons, preferably light-mediated manipulations of neuronal activity. Around this time, the so-called bacteriorhodopsins were described in prokaryotes. These bacteriorhodopsins are light-sensitive proton pumps which convert light into chemical energy by creating a proton gradient. Over the years, a wide range of light-sensitive membrane proteins has been discovered. In 2003, the group of Ernst Bamberg characterized the light sensitive cation channel channelrhodopsin-2 (ChR2) from the green alga Chlamydomonas reinhardtii [9] . ChR2 comprises an opsin with seven transmembrane helices forming a central pore and a covalently bound chromophore retinal. Upon absorption of a photon, the retinal undergoes a trans-cis isomerization to open the channel pore which allows cation influx according to the concentration gradient. This is in contrast to rhodopsin, the photoreceptor molecule in the vertebrate retina, a G-protein coupled receptor (GPCR). In case of GPCRs the conformational change activates a G-protein inducing a signal transduction cascade. Therefore, channelrhodopsins are opsins of class 1, whereas GPCRs are class 2 opsins. In 2005 Karl Deisseroth's group used viral gene transfer to achieve ChR2 expression in mouse post mitotic neurons [1] . Critical for the success of this method in neuroscience was the fact that at least in the mammalian brain no exogenous application of retinal is required as endogenous concentrations proved sufficient for the function of ChR2. This is an advantage over optochemical approaches reliant on exogenously added photosensitive ligands. In contrast, ChR2 is an entirely genetically encoded actuator, for the first time combining strategies of genetic expression with optical stimulation into a single-component system, thereby justifying the term "optogenetics". Blue light illumination of ChR2-expessing neurons induces a cation (mainly Na + ) influx which then causes depolarization of the neuronal cell membrane. If sufficiently depolarized the neuron may generate an optically induced action potential. Besides ChR2, many more depolarizing cation channels with different spectra of excitation wavelengths and kinetics have been characterized over the last few years. Light-mediated inhibition of neuronal activity needs active ion transport carried out by ion 81 e-Neuroforum 4 · 2012 | pumps such as the light-driven proton pump halorhodopsin from Natronomonas pharaonis (NpHR) [5] and the chloride pump archaerhodopsin-3 (Arch, ArchT) from Halobacterium sodomense [3] . Here we present the main working steps of an optogenetic experimental approach in the mammalian brain as well as some selected applications in rodents and primates. It is not our primary goal to present a complete overview of different expression strategies and optogenetic actuators. The main focus lies on a more comprehensive description of basic capabilities and limitations of this new method.
From correlative to causal analysis of neuronal network function
Unlike the correlative descriptive analysis, a causal approach requires a direct and specific manipulation of neuronal network components, from single cell to the population level. Ideally the grade of specificity of manipulation tools should match the level of descriptive analysis. Differential gene expression is the key to morphological and functional diversity of neuronal networks. It represents the basis of descriptive analyses involving the use of fluorescent antibodies or transgenic strategies for differential, promoter-driven, expression of fluorescent proteins. Optogenetics provides specificity of manipulation by transferring the gene for the optogenetic actuator combined with a cell type specific promoter. It must be kept in mind, however, that a massive expression of exogenous membrane proteins may lead to a significant alteration of the structure and the dynamics of the neuronal cell membrane. Extensive control trials are, therefore, mandatory when choosing an optogenetic approach. Yet, optical stimulation is effective over relatively long distances. One can stimulate for example the pyramidal cells of the cortical layer V in mice by an optical fiber not penetrating the pia, over a distance of 600 µm. Lensed optical fibers and holographic microscopic methods make it possible to define the stimulated region ranging from less than a micrometer to several millimeters. There are two main approaches to achieve opsin expression in neurons: viral gene transfer or transgenic methods. With viral gene transfer the spatial extent of the transduced area depends on the virus titer and the injected volume, whereas the transgenic method typically yields brainwide expression. This distribution significantly influences the specificity of the optogenetic stimulation. The most widely used transgenic mouse is the Thy1-ChR2 mouse line (line 18). In contrast to local injection, a whole network in these mice can be stimulated by a single local stimulation.
Electrophysiological single cell recording remained so far unrivalled in terms of temporal precision and immediate manipulation of the membrane potential. Electrical stimulation entails however the crucial disadvantage of poor specificity, although by accurately choosing the parameters the stimulation effects can be confined to selected neuronal elements. For example, it has been shown that mostly axons are recruited during electrical stimulation with common parameters. Using optogenetics, a considerably higher specificity of manipulation is possible, since the stimulation is limited strictly to expressing and illuminated neuronal elements (. Fig. 1 ). Another inevitable problem is the electrical artifact generated when using electrical stimulation. This phenomenon can be bypassed by combining optogenetic stimulation with electrophysiological recording, even though a photoelectrical artifact, the so-called Becquerel effect, can occur. It is the consequence of photons hitting only a part of the recording metal of the electrodes. This creates a current between the non-uniform illuminated contacts leading to a voltage change. This problem can be avoided by fine-tuning the angle of light incidence relative to µA, 300 Hz, biphasic 150 µs long pulses) activates a wide spread network, which is mainly based on the stimulation of afferent or passing by axons. b Optogenetic stimulation of a local opsin-expressing area leads to a locally limited activation of neurons, due to the limited spread of light. While axons usually can be stimulated optogenetically, non-expressing axons are not activated, because they originate from a noninjected area [4] the electrode, or by using optical detection of neuronal activity ("all optical physiology").
Optogenetic actuators
All opsins have a common feature: they lack an endogenous fluorophore. Therefore, to determine the expression efficiency and the cellular localization, opsins are fused with fluorophores such as GFP, YFP or mCherry, which are also genetically encoded. The activation threshold of ChR2 corresponds to a light density of 1 mW/ mm 2 . Normally this cannot be attained in a simple imaging experiment so that the illumination of the ChR2-YFP protein with 488 nm for the purpose of localization is unlikely to activate ChR2.
Genetically encoded optogenetic actuators can be subdivided into two classes, first those that are light-sensitive depolarizing ion channels and, second, the light-driven hyperpolarizing ion pumps (. Tab. 1). Notably, the light driving the channels serves merely for the conformational change of the chromophore retinal. The opening kinetics are mainly determined by the protein structure of the channel. This should be considered when designing optogenetic stimulation parameters and choosing suitable actuators. For instance, stimulation pulses of 1-3 ms duration can already effectively activate the most widely used mutant ChR2(H134R). However, this channel closes with an exponential time constant of 18 ms. Thus, after this period still 37% of the channels are in the open conformation confining the maximal effective stimulation frequency to 40 Hz in this mutant. In the authors' view, it exhibits among all fast opsins the best compromise in terms of high expression level, low cytotoxicity, and speed. Besides those fast channels, new variants have been generated by point mutation, resulting in time constants ranging from seconds to minutes: the so-called step function opsins (SFO). These can for example be used to modulate the excitability of a neuronal network via subthreshold tonic depolarization.
Hyperpolarizing inhibitory ion pumps are able to transport ions against their concentration gradient during continuous absorption of light, requiring constant light illumination. Currently the chloride pump halorhodopsin (eNpHR3.0) as well as the proton pump archaerhodopsin-3 (Arch, ArchT) are the most common hyperpolarizing opsins. It is still a matter of debate whether cellular physiology is disturbed more severely by a shift in the chloride equilibrium potential (NpHR) or by a change of local pH (Arch/ArchT).
Methods of cell specific expression of optogenetic actuators
In the course of developing somatic gene therapy a multitude of viral vectors have been designed which are able to transfer exogenous DNA into postmitotic neurons.
The third generation adeno-associated viruses (AAVs) have proven to be reliable and secure viral vector in rodents and primates. Most commonly serotype 2 is utilized. It can be pseudotyped with various other serotypes, changing the tropism of the virus. An example of used nomenclature in case of AAV serotype 2, pseudotyped with serotype 5 is AAV2/5 or short AAV5. In primates and rodents AAV2, AAV2/1 and AAV2/5 have already been tested. Yet, lentiviruses have also been successfully used. However, on average they yield a lower expression and diffusion rate, probably due to the significantly larger diameter of the particle (100 nm instead of 20 nm in AAV) and their lower titers. In addition, lentiviruses exhibit a higher immunogenic potential.
One of the most crucial prerequisites of a successful optogenetic experiment is a strong opsin expression level. Opsins need to be expressed in high numbers to achieve an effective in vivo stimulation/inhibition. On the one hand, this depends on the tropism and the titer of the virus. On the other hand, the strength of the promoter can be an important limitation. There are many cell-specific promoters, especially in the case of interneurons (GAD67, 5HT3) which are convenient for descriptive analyses, applying fluorophore expression. However, this is far from sufficient for a functionally effective optogenetic stimulation.
A limiting factor for the use of AAVs in optogenetics is the limited capacity of the vector with 4.7 kb at the maximum. Unfortunately this is not sufficient for many cell specific promoters. The following promoters, however, can be inserted upstream of the opsin gene yielding a specific and effective expression: CamKII (excitatory neurons), hSyn (all neurons), hThy-1 (human and murine version of the promoter, all neurons, lower expression than hSyn), Ef1a (all cells including microglia), CAG (all cells including microglia, extremely high expression rate), SST (somatostatin-positive neurons), hypocretin (hypocretin-positive neurons).
The limitations imposed by the weakness of a promoter can be circumvented by using the Cre/loxP system (. Fig. 2,  3) . Here, the fusion protein opsin/fluorophore and a strong ubiquitous promot-
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Optogenetics · Light stimulation · Viral gene transfer · Causal manipulation of neuronal networks · Circuit-based therapies er (EF1α) are inversed in a viral plasmid, and the construct is double floxed with two loxP sequences. In a second viral plasmid the enzyme Cre recombinase is under the control of a cell specific promoter (e.g., GAD67, PV). Co-injecting both viruses results in a recombination in the target cell as even the limited strength of the cell-specific promoter provides sufficient Cre-levels. After recombination, the opsin is expressed under the control of the strong ubiquitous promoter (EF1α) avoiding low expression by the cell specific promoter. In addition, to co-injecting two viral vectors, the floxed optogenetic vector can be introduced in one of the fast growing numbers of available transgenic Cremouse lines-an option which is widely used in research.
Methods of optical stimulation
The next step in an optogenetic experimental approach is to choose a suitable light source. Depending on the opsin a local light density of 1-10 mW/mm 2 must be reached. Higher values lead to increased photo currents. However, all opsins within the illuminated area are usually already activated by 50 mW/mm 2 . Normally these high light densities can be obtained by coupling 50-100 mW lasers either directly in an optic fiber or in a microscope system. When lasers are coupled in a glass fiber, the size of the illuminated area can be freely defined up to a diameter of 500 µm. Lens-based optic fibers allow illuminating an area of only a few micrometers. Optical fibers can be applied acutely or chronically (e.g., implanting a tip of an optic fiber, which can be attached to a long fiber with a connector). Whereas acutely inserted fibers also allow application of pharmacological manipulations at the same site, they break easily. By contrast, no pharmacological manipulations are possible with chronic implants (except for a cannula implanted directly next to the fiber). They are, however, far more robust and stay intact for weeks up to months. Laser diodes are a widely used light source and it is easy to couple them to optical fibers, although up to now only laser diodes with wavelengths below 500 nm are commercially available. Light-emitting diodes (LEDs) can be applied directly to the brain tissue, and many different wavelengths are available. It is important to note, however, that the produced heat must be dissipated to prevent tissue damage. LEDs can be coupled directly to a fiber with the dis- advantage of significantly decreasing their light output. For future applications it is worthwhile to employ small, completely implantable LEDs. Prototypes already exist but they have not been tested in vivo yet.
Applications in neuroscience
Taking advantage of the cell specificity of the optogenetic approach as described above, our understanding of the complexity of neuronal networks has considerably grown over the last years. This includes the causal analyses of circuit disorders like autism and schizophrenia [12] , the demonstration of the mechanism of neurovascular coupling in fMRI [7] , and the improved understanding of the differentiation of stem cells into neurons [10] . Here we present three examples from this great variety of studies:
Combining optogenetic stimulation with optical methods for the detection of neuronal activity
In addition to the optogenetic approach for functional manipulation, methods for optical detection of neuronal activity have been developed during the last few years. For this purpose, fluorescent indicators have been employed, changing fluorescence emission depending on the intracellular calcium levels. A neuronal action potential leads to a defined increase of the somatic intracellular calcium level, mainly due to the opening of voltage-gated calcium channels in the neuronal cell membrane. Hence, an increased emission of fluorescence by the calcium indicator can be regarded as the optical correlate of suprathreshold neuronal activity. In the presented study, ChR2 was expressed in the mouse visual cortex by means of viral gene transfer. Two weeks after virus injection the fluorescent calcium indicator Oregon-Green BAPTA1 (OGB1) was injected into the visual cortex. Via an optic fiber of 200 µm diameter, blue light was applied to activate both the indicator and the opsin. As mentioned above, the activation of ChR2 requires a minimal effective light density of 1 mW/mm 2 . To excite OGB1 a light density of 0.01 mW/mm 2 already suffices which is clearly below the ChR2 threshold. The intensity of the emitted light is detected by the optic fiber-based detection setup, containing a photodiode allowing for a high temporal resolution in the kHz range. Thereby, it is possible to measure the sum of neuronal activity of the neuronal population within the illuminated area [6] . As a first step, spontaneous slow calcium waves have been detected in the visual cortex of anesthetized mice. This population activity is related to slow oscillations at a frequency of <1 Hz, playing a major role in memory formation and control of fast oscillations. The origin of these oscillations had yet to be determined in a causal approach. Genetically defined pyramidal cells in the cortical layer V were activated by applying light pulses of high intensity, resulting in a global calcium wave. This provides causal evidence that a local cortical neuronal population is capable of inducing a global calcium wave, indistinguishable from spontaneous waves (. Fig. 4 ).
Optogenetics in conscious animals, behaviour
Behavioral experiments combined with optogenetic manipulations offer key ad- vantages concerning the temporal structure of an experiment. In contrast to the extended washout times of pharmacological reagents, the effects of light are immediately reversible which can reduce the duration of behavioral tests to only one day compared to the previously required several days. Testing the behavior, e.g., in an elevated plus maze combined with optogenetics, allows within-subject comparisons between conditions (light on/off) during a single experimental session [11] .
Apart from these benefits of optogenetic stimulation, there are several important aspects that need to be considered when applying this novel tool. An important limiting factor is the heat development due to the light exposure. High light intensities during constant or almost constant illumination can induce heatdependent alterations in the illuminated cells. The heat can alter cell activity or lead to cell damage. Therefore, every test group should include a number of control animals. Most suitable are YFP controls, i.e., animals that are treated exactly like the test animals except for the injected virus which contains only the fluorophore gene and lacks the opsin gene. A further limiting factor in optogenetics is the potential toxicity of very high expression levels of the opsin and the fluorophore due to the use of strong promoters or very long expression times. If the expression exceeds certain levels, other important endogenous channels are at risk to be displaced from the cell membrane. In order to rule out this effect, intracellular recordings from brain slices performed under identical conditions are recommended (i.e., same opsin, cell type, viral vector, amount of virus, virus titer, expression time, and light intensity).
Optogenetics in primates
Non-human primates are the prime model of fine motor control and higher cognitive functions. It is therefore desirable to adapt optogenetic techniques to this model. First attempts to establish them in rhesus monkeys have shown that the principles of optogenetic manipulation of neurons are also functional in primates and that the same vectors, opsins, and promoters can be used [4] .
Injecting AAVs into the motor and premotor cortex reliably results in a strong opsin expression in up to 80% of neurons. The hSyn promoter has proven to be particularly effective. Subsequent optical stimulation with blue light activates the ChR2-expressing neurons with millisecond precision. On the other hand, halorhodopsin-expressing neurons can be completely turned off, i.e., spontaneous action potentials are suppressed. The step function opsin (SFO), a particularly light sensitive opsin with slow kinetics, can induce long lasting responses. This increase in action potential generation can be immediately reversed by a yellow light pulse returning the opsin into its dark state.
Whereas the modulation of neuronal activity did not pose any problems, influencing behavior in primates turned out to be very challenging. Directly adjacent to spots in motor cortex at which hand twitches could be evoked by electrical stimulation, optogenetic stimulation did not evoke movements. It remains to be determined whether this is only due to the larger brain volume of primates as compared to rodents or whether more complex neuronal circuits and cognitive strategies might play a role. Nevertheless, a number of studies have shown that optogenetic manipulations can influence behavior in non-human primates, too. For instance, the reaction times from an instructive cue to a reach are significantly increased by perturbing neural activity in premotor cortex. Furthermore, stimulation of the frontal eye field (FEF) or of the primary visual cortex is able to influence the direction of eye movements. Common to all these successful applications is that they influence behavior rather than causing it.
Preclinical applications
We provide two examples of applications of optogenetic strategies which have a high likelihood of clinical implementation in the midterm. Probable targets include experimental therapies of retinitis pigmentosa and peripheral nervous system dysfunctions.
Retinitis pigmentosa encompasses a diversity of hereditary diseases which lead to incurable blindness. Early degeneration of the highly sensitive rods is the common feature of all types of these degenerative Typically shorter pulses of 1-2 ms are used. c Green light suppresses action potentials in a NpHR2.0 expressing cell. d The so-called step function opsin (SFO) is stimulated by a single short pulse of blue light (10 ms). Repeated pulsing leads to an accumulation of the effect until a plateau of neuronal activity is reached. The effect of a single light pulse can last several seconds, in newer versions of the opsin up to 30 min. This effect can be reversed by a yellow light pulse [4] diseases, whereas the more robust cones seem to persist longer. It has been demonstrated that expressing the opsin NpHR in the cones was able to restore the natural phototransduction cascade and, thus, rescue to some extent the light sensitivity in the mouse model of retinitis pigmentosa. Moreover in ex vivo human retina the light sensitivity of photoreceptors was reactivated. A considerable number of patients may benefit from these therapeutic options [2] . Another possible clinical application is based on the stimulation of the peripheral nervous system. Electrical stimulation has been used for this purpose so far. However, it recruits particularly the large, fast fatiguing motor units if a weak electrical stimulation is applied. This reverse order of natural recruitment acts as a limiting factor for therapeutic applications. In contrast, optogenetic stimulation of peripheral nerve fibers has been shown to avoid this problem increasing the effectiveness of this stimulation.
It is still far from clear if optogenetic manipulations will find their way into clinics. Advancing strategies for safe systemic gene transfer is in our view mandatory for this step.
